share_log

NeuroPace Q1 2024 GAAP EPS $(0.32) Beats $(0.33) Estimate, Sales $18.124M Beat $17.302M Estimate

NeuroPace Q1 2024 GAAPのEPSは$(0.32)で、$(0.33)の評価を上回り、$18,124Mの売上は$17,302Mの評価を上回る。

Benzinga ·  05/08 16:26

NeuroPace (NASDAQ:NPCE) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.33) by 3.03 percent. This is a 21.95 percent increase over losses of $(0.41) per share from the same period last year. The company reported quarterly sales of $18.124 million which beat the analyst consensus estimate of $17.302 million by 4.75 percent. This is a 25.23 percent increase over sales of $14.472 million the same period last year.

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする